Conjugated linoleic acid evokes de-lipidation through the regulation of genes controlling lipid metabolism in adipose and liver tissue.
Conjugated linoleic acid (CLA) is a unique lipid that elicits dramatic reductions in adiposity in several animal models when included at < or = 1% of the diet. Despite a flurry of investigations, the precise mechanisms by which conjugated linoleic acid elicits its dramatic effects in adipose tissue and liver are still largely unknown. In vivo and in vitro analyses of physiological modifications imparted by conjugated linoleic acid on protein and gene expression suggest that conjugated linoleic acid exerts its de-lipidating effects by modulating energy expenditure, apoptosis, fatty acid oxidation, lipolysis, stromal vascular cell differentiation and lipogenesis. The purpose of this review shall be to examine the recent advances and insights into conjugated linoleic acid's effects on obesity and lipid metabolism, specifically focused on changes in gene expression and physiology of liver and adipose tissue.
House
R L
RL
Department of Animal Science & Functional Genomics Program, North Carolina State University, Raleigh, NC 27695, USA.
Cassady
J P
JP
Eisen
E J
EJ
McIntosh
M K
MK
Odle
J
J
D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D002417:Cattle; D004734:Energy Metabolism / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D044243:Linoleic Acids, Conjugated / Q000494:pharmacology*; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism*; D051379:Mice; D009765:Obesity / Q000235:genetics / Q000378:metabolism*; D009929:Organ Size / Q000187:drug effects; D051381:Rats
D044243:Linoleic Acids, Conjugated